Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 82

Sort by

Sort Order Select

Journal Articles

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up

Matthew Danish, MD MS, Tabitha Copeland, MD, Joseph Ho, MD, Mansi Shah, MD BA, Dennis Cooper, MD

Blood (2019) 134 (Supplement_1): 4726.

https://doi.org/10.1182/blood-2019-131551

Published: 2019

Journal Articles

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Arya Mariam Roy, MD, Manojna Konda, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4848.

https://doi.org/10.1182/blood-2019-131489

Published: 2019

Journal Articles

The Impact of a Mandatory Prescription Drug Monitoring Program (PDMP) on Opioid Prescription Among Sickle Cell Disease Patients By Emergency Medicine Physicians in Community Teaching Hospitals in Philadelphia

Sufana Shikdar, MD MPH, Vinay Edlukudige Edlukudige Keshava, MBBS, Peter Lambert, MD, Sindusha Gudipally, MD, Anthony Esposito, Brad Bendesky, MD, Eric Green, MDMSc

Blood (2019) 134 (Supplement_1): 4703.

https://doi.org/10.1182/blood-2019-122394

Published: 2019

Journal Articles

Assessment of Utilization of Outpatient Based Treatment for Low Risk Patients with Pulmonary Embolism in Two Community Teaching Hospitals

Kavita Agrawal, Nirav Agrawal, Harsha Adnani, Anjali Kakwani

Blood (2019) 134 (Supplement_1): 5779.

https://doi.org/10.1182/blood-2019-131294

Published: 2019

Journal Articles

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Renee Cheng, MD, Rishi Patel, MD, Sandra Kang, MD, Frances Tian, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Jayleen Patel, MD, Netanel Zilberstein, MD, Victor R Gordeuk, MD, Michel Gowhari, DO

Blood (2019) 134 (Supplement_1): 3396.

https://doi.org/10.1182/blood-2019-130877

Published: 2019

Journal Articles

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Ashley Thrower, BS, Zhou Laura, Vimal K. Derebail, MD, David Wichlan, Ashley Smith, RN, Jianwen Cai, PhD, Kenneth I. Ataga, MD

Blood (2019) 134 (Supplement_1): 2308.

https://doi.org/10.1182/blood-2019-131368

Published: 2019

Journal Articles

Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors

Laura F. Newell, MD, Rebekah Knight, Kelsea Shoop, Sara Murray, Rogelyn Kwock, NP, Carol Jacoby, NP, Susan Slater, NP, Bryon Allen, NP, Brad Cota, MBA, Peggy Appel, Rachel J. Cook, MD, Richard T. Maziarz, MD, Gabrielle Meyers, MD

Blood (2018) 132 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2018-99-120342

Published: 2018

Journal Articles

Cell-Free Mitochondrial DNA Is Elevated in Sickle Cell Disease Patients, and Serve As a Potential Proinflammatory DAMP

Laxminath Tumburu, PhD, Shohini Ghosh-Choudhary, Emilia Alina Barbu, Simon Yang, Lauren D Harrison Ware, Ilker Tunc, PhD, Fayaz Tasaduck Seifuddin, Mehdi Pirooznia, MD PhD, Jun Zhu, PhD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP

Blood (2018) 132 (Supplement 1): 1068.

https://doi.org/10.1182/blood-2018-99-118440

Published: 2018

Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD

Blood (2018) 132 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2018-99-119720

Published: 2018

Journal Articles

Opioid Dependency Significantly Increases Complications and Mortality in Sickle Cell Disease

Stuthi Pavani Perimbeti, MD MPH, Kevin Ye Hou, MD, Sabarina Ramanathan, MD, Adonas Woodard, MD, Daniel Kyung, MD, Priyadarshini Pathak, MBBS, Rishi Shrivastav, MD, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 4701.

https://doi.org/10.1182/blood-2018-99-120012

Published: 2018

Journal Articles

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Yutaka Niihara, MD, Rafael Razon, MD, Suvankar Majumdar, MD, Brian Claggett, PhD, Onyinye C. Onyekwere, MD, Alan Ikeda, MD, Tammuella Singleton, MD, Andrew Kohei Wood, MS, Rajani Singh, BS, Lan Tran, MPH, Charles William Stark, PharmD

Blood (2017) 130 (Supplement 1): 685.

https://doi.org/10.1182/blood.V130.Suppl_1.685.685

Published: 2017

Journal Articles

Effects of N-Acetylcysteine Infusion in Patients with Sickle Cell Disease during Vaso-Occlusive Crises

Hasan Ozpolat, MD, Junmei Chen, PhD, Xiaoyun Fu, PhD, Melissa Dominguez, MA, Jennie Le, BS, Minhua Ling, PhD, Sophie Schmitter, BS, Sarah Ruuska, MPH, Dominic W. Chung, PhD, Jose A. Lopez, MD, Barbara Konkle, MD

Blood (2017) 130 (Supplement 1): 2238.

https://doi.org/10.1182/blood.V130.Suppl_1.2238.2238

Published: 2017

Journal Articles

Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 532.

https://doi.org/10.1182/blood.V130.Suppl_1.532.532

Published: 2017

Journal Articles

Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle Cell Disease

Mariam Kayle, PhD RN, Nirmish Shah, MD, Paula Tanabe, PhDRN, Richard Sloane, MPH, Gary Maslow, MD, Wei Pan, PhD, Sharron Docherty, PhD

Blood (2017) 130 (Supplement 1): 131.

https://doi.org/10.1182/blood.V130.Suppl_1.131.131

Published: 2017

Journal Articles

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Julie Kanter, MD, Darla Liles, MD, Rodolfo Cancado, MD, PhD, João Friedrisch, MD PhD, Troy H. Guthrie, MD, Jennifer Knight-Madden, MBBS, PhD, Ofelia A. Alvarez, MD, Victor R. Gordeuk, MD, Sandra Gualandro, MD PhD, Marina Pereira Collela, MD PhD, Wally R. Smith, MD, Scott A. Rollins, PhD, Jonathan W. Stocker, PhD, Russell P. Rother, PhD

Blood (2016) 128 (22): 1.

https://doi.org/10.1182/blood.V128.22.1.1

Published: 2016

Journal Articles

The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients

Nene Kalu, LGSW, Patricia A. O'Neal, MD, Catherine Nwokolo, RN, Sharmin Diaz, FNP, Oluwakemi Owoyemi, MD MPH

Blood (2016) 128 (22): 5913.

https://doi.org/10.1182/blood.V128.22.5913.5913

Published: 2016

Journal Articles

Temperature and Humidity Effects on Acute Vaso-Occlusive Pain Episodes in Sickle Cell Disease

Fuad El Rassi, MD, Eldrida Randall, MS, Sidney F. Stein, MD, Hanna Jean Khoury, MD, James R. Eckman, MD, Morgan L. McLemore, MD

Blood (2015) 126 (23): 992.

https://doi.org/10.1182/blood.V126.23.992.992

Published: 2015

Journal Articles

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Taylor Mueller, BS, LaShon Sturgis, MD PhD, Patrick Loeffler, BS, Ann-Marie Kuckinski, PhD, Abdullah Kutlar, MD, Robert Gibson, PhD, Matthew Lyon, MD

Blood (2015) 126 (23): 5568.

https://doi.org/10.1182/blood.V126.23.5568.5568

Published: 2015

Journal Articles

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

Christopher Lemieux, MD, Imran Ahmad, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Jean Roy, MD PhD, Silvy Lachance, MD

Blood (2015) 126 (23): 3171.

https://doi.org/10.1182/blood.V126.23.3171.3171

Published: 2015

Journal Articles

Does Adherence to Hydroxyurea Affect Emergency Department Observation Unit Utilization?

Taylor Mueller, BS, Patrick Loeffler, BS, Xu Hongyan, PhD, Abdullah Kutlar, MD, Matthew Lyon, MD, LaShon Sturgis, MD PhD, Robert Gibson, PhD

Blood (2015) 126 (23): 4443.

https://doi.org/10.1182/blood.V126.23.4443.4443

Published: 2015

NARROW

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

The Impact of a Mandatory Prescription Drug Monitoring Program (PDMP) on Opioid Prescription Among Sickle Cell Disease Patients By Emergency Medicine Physicians in Community Teaching Hospitals in Philadelphia

Assessment of Utilization of Outpatient Based Treatment for Low Risk Patients with Pulmonary Embolism in Two Community Teaching Hospitals

Implementation of a Standard Order Set at a Sickle Cell Acute Care Observation Unit

Opioid Analgesics Are Associated with Albuminuria in Adult Patients with Sickle Cell Anemia

Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors

Cell-Free Mitochondrial DNA Is Elevated in Sickle Cell Disease Patients, and Serve As a Potential Proinflammatory DAMP

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Opioid Dependency Significantly Increases Complications and Mortality in Sickle Cell Disease

Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events

Effects of N-Acetylcysteine Infusion in Patients with Sickle Cell Disease during Vaso-Occlusive Crises

Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies

Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle Cell Disease

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients

Temperature and Humidity Effects on Acute Vaso-Occlusive Pain Episodes in Sickle Cell Disease

Emergency Department Physicians Management Versus Hospitalists Service Management Admittance Rates for Sickle Cell Disease Patients from an Emergency Department Observation Unit

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

Does Adherence to Hydroxyurea Affect Emergency Department Observation Unit Utilization?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only